The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial
Abstract
Purpose: To evaluate the influence of adjuvant tamoxifen and exemestane on cognitive functioning in postmenopausal patients with breast cancer (BC). Patients and Methods: Neuropsychological assessments were performed before the start (T1) and after 1 year of adjuvant endocrine treatment (T2) in Dutch postmenopausal patients with BC, who did not receive chemotherapy. Patients participated in the international Tamoxifen and Exemestane Adjuvant Multinational trial, a prospective randomized study investigating tamoxifen versus exemestane as adjuvant therapy for hormone-sensitive BC. Results: Participants included 80 tamoxifen users (mean age, 68.7 years; range 51 to 84), 99 exemestane users (mean age, 68.3 years; range, 50 to 82), and 120 healthy controls (mean age, 66.2 years; range, 49 to 86). At T2, after adjustment for T1 performance, exemestane users did not perform statistically significantly worse than healthy controls on any cognitive domain. In contrast, tamoxifen users performed statistically significantly worse than healthy controls on verbal memory (P < .01; Cohen's d = .43) and executive functioning (P = .01; Cohen's d = .40), and statistically significantly worse than exemestane users on information processing speed (P = .02; Cohen's d = .36). With respect to visual memory, working memory, verbal fluency, reaction speed, and motor speed, no significant differences between the three groups were found. Conclusion: After 1 year of adjuvant therapy, tamoxifen use is associated with statistically significant lower functioning in verbal memory and executive functioning, whereas exemestane use is not associated with statistically significant lower cognitive functioning in postmenopausal patients with BC. Our results accentuate the need to include assessments of cognitive effects of adjuvant endocrine treatment in long-term safety studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Validity of the Trail Making Test as an Indicator of Organic Brain Damage
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,928
The Neuropsychological Assessment
Ogden, J. A. (2005) · Fractured Minds · doi:10.1093/oso/9780195171358.003.0002 · Cited by 4,364
(2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65186-5_302294 · Cited by 2,278
Comparative distribution of estrogen receptor-? and -? mRNA in the rat central nervous system
Shughrue, P. J., Lane, M. V., & Merchenthaler, I. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971201)388:4<507::aid-cne1>3.0.co;2-6 · Cited by 2,259
Reynolds, C. R., & Powel, J. (1988) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/3.4.397 · Cited by 2,095
Estrogen receptors and human disease
Deroo, B. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27987 · Cited by 1,320
Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
Riggs, B. L., & Hartmann, L. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022219 · Cited by 968
Rocca, W. A., Bower, J. H., Maraganore, D. M., Ahlskog, J. E., Grossardt, B. R., de Andrade, M., & Melton, L. J. (2007) · Neurology · doi:10.1212/01.wnl.0000276984.19542.e6 · Cited by 827
Van Breukelen, G. J. P. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.02.007 · Cited by 765
Effects of estrogen on memory function in surgically menopausal women
Phillips, S. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90007-t · Cited by 741
Activation of estrogen receptor-β regulates hippocampal synaptic plasticity and improves memory
Liu, F., Day, M., Muñiz, L. C., Bitran, D., Arias, R., Revilla-Sanchez, R., Grauer, S., Zhang, G., Kelley, C., Pulito, V., et al. (2008) · Nature Neuroscience · doi:10.1038/nn2057 · Cited by 505
Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer
Partridge, A. H., LaFountain, A., Mayer, E., Taylor, B. S., Winer, E., & Asnis-Alibozek, A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5451 · Cited by 482
Visual association test to detect early dementia of the Alzheimer type
Lindeboom, J. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.2.126 · Cited by 360
Fallowfield, L. J., Leaity, S. K., Howell, A., Benson, S., & Cella, D. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006263818115 · Cited by 354
Cognitive function in breast cancer patients prior to adjuvant treatment
Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9686-5 · Cited by 345
‘Chemobrain’ in breast carcinoma?: A prologue
Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20393 · Cited by 334
VAN DER ELST, W., VAN BOXTEL, M. P. J., VAN BREUKELEN, G. J. P., & JOLLES, J. (2006) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617706060115 · Cited by 334
Sherwin, B. B., & Henry, J. F. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.08.002 · Cited by 282
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Preliminary Assessment of Cognitive Function in Breast Cancer Patients Treated with Tamoxifen
Paganini-Hill, A., & Clark, L. J. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006426132338 · Cited by 227
Jenkins, V., Shilling, V., Fallowfield, L., Howell, A., & Hutton, S. (2004) · Psycho-Oncology · doi:10.1002/pon.709 · Cited by 227
Hormone replacement therapy for cognitive function in postmenopausal women
Lethaby, A., Hogervorst, E., Richards, M., Yesufu, A., & Yaffe, K. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003122.pub2 · Cited by 214
Estrogen- and tamoxifen-associated effects on brain structure and function
Eberling, J. L., Wu, C., Tong-Turnbeaugh, R., & Jagust, W. J. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.08.037 · Cited by 213
Bender, C. M., Sereika, S. M., Brufsky, A., Ryan, C. M., Vogel, V. G., Rastogi, P., Cohen, S. M., Casillo, F. E., & Berga, S. L. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318148b28b · Cited by 169
Meulen, E. F. J. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.021055 · Cited by 162
MacLennan, A. H., Henderson, V. W., Paine, B. J., Mathias, J., Ramsay, E. N., Ryan, P., Stocks, N. P., & Taylor, A. W. (2006) · Menopause · doi:10.1097/01.gme.0000191204.38664.61 · Cited by 160
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study
Collins, B., MacKenzie, J., Stewart, A., Bielajew, C. H., & Verma, S. (2008) · Psycho-Oncology · doi:10.1002/pon.1453 · Cited by 149
Advances in Adjuvant Endocrine Therapy for Postmenopausal Women
Lin, N., & Winer, E. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0946 · Cited by 144
Perez, E. A. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm263 · Cited by 142
Schilder, C. M. T., Eggens, P. C., Seynaeve, C., Linn, S. C., Boogerd, W. J., Gundy, C. M., Beex, L. V. A. M., van Dam, F. S. A. M., & Schagen, S. B. (2008) · Acta Oncologica · doi:10.1080/02841860802314738 · Cited by 122
Self-citationJenkins, V. A., Ambroisine, L., Atkins, L., Cuzick, J. M., Howell, A., & Fallowfield, L. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70207-9 · Cited by 119
Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen
Ariazi, E. A., Leitão, A., Oprea, T. I., Chen, B., Louis, T., Bertucci, A. M., Sharma, C. G. N., Gill, S. D., Kim, H. R., Shupp, H. A., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0312 · Cited by 72
Winkens, B., van Breukelen, G., Schouten, H. J. A., & Berger, M. P. F. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2007.04.002 · Cited by 69
Wise, P. M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.046 · Cited by 66
Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer
Buzdar, A. U., Coombes, R. C., Goss, P. E., & Winer, E. P. (2007) · Cancer · doi:10.1002/cncr.23193 · Cited by 52
Fröjdh, K., Håkansson, A., & Karlsson, I. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1102 · Cited by 49
Hirshman, E., Merritt, P. S., Wang, C. C. L., Wierman, M. E., Budescu, D. V., Kohrt, W. M., Templin, J. L., & Bhasin, S. (2004) · Hormones and Behavior · doi:10.1016/j.yhbeh.2003.09.008 · Cited by 46
Schilder, C. M. T., Seynaeve, C., Linn, S. C., Boogerd, W. J., Gundy, C. M., Beex, L. V. A. M., van Dam, F. S. A. M., & Schagen, S. B. (2009) · Psycho-Oncology · doi:10.1002/pon.1595 · Cited by 38
Self-citationClinical management of adverse events in adjuvant therapy for hormone-responsive early breast cancer
Monnier, A. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm264 · Cited by 33
AROMATASE INHIBITORS AND MENTAL FUNCTION
Tralongo, P., Dimari, A., & Repetto, L. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53031_2.x · Cited by 9
Cited by
Prevalence, mechanisms, and management of cancer-related cognitive impairment
Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864260 · Cited by 745
Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science
Ahles, T. A., Root, J. C., & Ryan, E. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.0116 · Cited by 704
Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0827 · Cited by 535
Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21258 · Cited by 532
Self-citationJim, H. S. L., Phillips, K. M., Chait, S., Faul, L. A., Popa, M. A., Lee, Y.-H., Hussin, M. G., Jacobsen, P. B., & Small, B. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5640 · Cited by 410
Metadata
- Authors
- Schilder, C. M., Seynaeve, C., Beex, L. V., Boogerd, W., Linn, S. C., Gundy, C. M., Huizenga, H. M., Nortier, J. W., van de Velde, C. J., van Dam, F. S., & Schagen, S. B.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-03-10
- Volume
- 28
- Issue
- 8
- Pages
- 1294-1300
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2150329556
- Cited by
- 269
- References
- 43
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.